As of 2025-07-12, the Relative Valuation of Fate Therapeutics Inc (FATE) is (22.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.15 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -2014.6%.
The range of the Relative Valuation is (21.70) - (29.80) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 19.4x | 14.5x |
| Forward P/E multiples | 13.5x - 21.5x | 14.2x |
| Fair Price | (21.70) - (29.80) | (22.02) |
| Upside | -1986.5% - -2691.0% | -2014.6% |
| Date | P/E |